Health Care Quality, Access, and Evaluation: News and Research on Clinical Trials, Phase II as Topic

MeSH tree: N05.715.360.330.250.250.210

New drug doubles 1-year survival in pancreatic cancer trial

Pancreatic cancer is one of the deadliest cancers and among the hardest to treat, with most patients surviving less than a year after diagnosis. But a new drug developed at Northwestern University may soon help patients live ...